Are there any food taboos when taking osimertinib/osimertinib?
Osimertinib/Osimertinib is a targeted drug for non-small cell lung cancer (NSCLC). Generally speaking, there are no specific taboo foods that are directly related to the taking of Osimertinib/Osimertinib. However, some foods may affect the absorption and metabolism of medications or interact with their possible side effects. Therefore, while taking osimertinib/osimertinib, patients may need to pay attention to the following foods:
1.Grapefruit and citrus fruits: Grapefruit and citrus fruits contain naringenin, which can affect the metabolic pathway of drugs, causing the concentration of drugs in the body to increase or decrease. Although the interaction between osimertinib and naringenin is unknown, patients are advised to avoid excessive consumption of grapefruit and citrus fruits for safety reasons.

2.High-fat food: High-fat food may delay the absorption of the drug, thereby affecting the efficacy of osimertinib/osimertinib. Therefore, it is recommended that patients try to avoid eating high-fat foods before and after taking Osimertinib/Osimertinib, especially while taking the drug.
3.Alcoholic beverages: Alcohol may affect drug metabolism and side effects. While taking osimertinib/osimertinib, patients should try to limit or avoid drinking alcohol to reduce the possibility of drug interactions.
4.Coffee and tea: Coffee and tea contain ingredients such as caffeine and theophylline. These substances may affect the metabolism of osimertinib/osimertinib. Although drinking in moderation usually does not cause problems, patients should avoid excessive intake.
In addition to the foods mentioned above, under normal circumstances, osimertinib/osimertinib does not require special dietary taboos. However, patients should avoid any foods that may cause allergic or adverse reactions, as well as foods that may interact with medications. Before starting osimertinib/osimertinib, patients can consult their physician or professional healthcare provider for more information about diet and drug interactions and adjustments to their individual circumstances.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)